- Home
- SKYW vs IRON Comparison
SKYW vs IRON Comparison
Compare SKYW & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYW
- IRON
- Stock Information
- Founded
- SKYW 1972
- IRON 2017
- Country
- SKYW United States
- IRON United States
- Employees
- SKYW N/A
- IRON N/A
- Industry
- SKYW Air Freight/Delivery Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- SKYW Consumer Discretionary
- IRON Health Care
- Exchange
- SKYW Nasdaq
- IRON Nasdaq
- Market Cap
- SKYW 4.2B
- IRON 3.4B
- IPO Year
- SKYW N/A
- IRON N/A
- Fundamental
- Price
- SKYW $99.72
- IRON $92.73
- Analyst Decision
- SKYW Strong Buy
- IRON Strong Buy
- Analyst Count
- SKYW 3
- IRON 12
- Target Price
- SKYW $129.00
- IRON $108.83
- AVG Volume (30 Days)
- SKYW 300.9K
- IRON 519.5K
- Earning Date
- SKYW 10-30-2025
- IRON 11-06-2025
- Dividend Yield
- SKYW N/A
- IRON N/A
- EPS Growth
- SKYW 78.86
- IRON N/A
- EPS
- SKYW 10.47
- IRON N/A
- Revenue
- SKYW $3,978,113,000.00
- IRON N/A
- Revenue This Year
- SKYW $16.73
- IRON N/A
- Revenue Next Year
- SKYW $3.98
- IRON N/A
- P/E Ratio
- SKYW $9.52
- IRON N/A
- Revenue Growth
- SKYW 19.27
- IRON N/A
- 52 Week Low
- SKYW $74.70
- IRON $30.82
- 52 Week High
- SKYW $135.57
- IRON $97.12
- Technical
- Relative Strength Index (RSI)
- SKYW 53.73
- IRON 65.99
- Support Level
- SKYW $91.84
- IRON $87.94
- Resistance Level
- SKYW $101.54
- IRON $97.12
- Average True Range (ATR)
- SKYW 3.06
- IRON 4.03
- MACD
- SKYW 0.31
- IRON 0.02
- Stochastic Oscillator
- SKYW 79.90
- IRON 71.58
About SKYW SkyWest Inc.
SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. Generally, SkyWest provides regional flights, and utilizes its smaller, lower-cost aircraft to carry passengers that booked tickets through airlines. It partners with carriers across the world to fly and operate aircraft for a fee. SkyWest may use the carriers's brand and ground support to coordinate marketing and easily transport passengers. The company has two reportable segments: SkyWest Airlines, which generates maximum revenue, and SkyWest Leasing.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.